arrow
Back
X

Xavier Leleu

University of Poitiers

93H-index
1.2KPaper Count
4.2WCitation Count
Published Papers 174
Publication Date
Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis
errLeukemia
IF13.4
err2026-08-24
err0
errOAAI
errThierry Facon; Shaji K. Kumar; Robert Z. Orlowski; Nizar Bahlis; Philippe Moreau; Hartmut Goldschmidt; Supratik Basu; Cyrille Hulin; Sonja Zweegman; Katja Weisel; Aurore Perrot; Caroline Jacquet; Noopur Raje; Salomon Manier; Ajai Chari; Markus Hansson; Mohamad Mohty; Michel Delforge; Torben Plesner; Gordon Cook; Xavier Leleu; Hang Quach; Christopher P. Venner; Mourad Tiab; Margaret Macro; Laurent Frenzel; George Wang; Huiling Pei; Kasey Bolyard; Robin Carson; Fredrik Borgsten; Saad Z. Usmani
errShare
errSave
Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study
errLeukemia
IF13.4
err2026-08-13
err0
PREAI
errCyrille Touzeau; Aurore Perrot; Cyrille Hulin; Mammoun Dib; Gedeon Agbetsivi; Laure Vincent; Thierry Facon; Xavier Leleu; Niels W.C.J. van de Donk; Annemiek Broijl; Sonja Zweegman; Michel Delforge; Jill Corre; Pieter Sonneveld; Ariane Boumendil; Philippe Moreau
errShare
errSave
Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial
err2026-07-03
err0
errOAAI
errAurore Perrot; Cyrille Touzeau; Stéphane Minvielle; Cyrille Hulin; Denis Caillot; Salomon Manier; Xavier Leleu; Cécile Sonntag; Karim Belhadj; Bertrand Arnulf; Thomas Chalopin; Jean-Richard Eveillard; Martine Escoffre-Barbe; Lionel Karlin; Laure Vincent; Margaret Macro; Hervé Avet-Loiseau; Soraya Wuilleme; Ariane Boumendil; Jill Corre; Philippe Moreau
errShare
errSave
Infections in Patients Receiving Daratumumab for Newly Diagnosed Multiple Myeloma: A Pooled Analysis of MAIA and ALCYONE
err2026-05-07
err0
errOAAI
errNizar Bahlis; Thierry Facon; Jesus San-Miguel; Saad Z. Usmani; Meletios A. Dimopoulos; Philippe Moreau; Sonja Zweegman; Aurore Perrot; Salomon Manier; Ajai Chari; Noopur Raje; Robert Z. Orlowski; Hartmut Goldschmidt; Supratik Basu; Cyrille Hulin; Katja Weisel; Mohamad Mohty; Xavier Leleu; Torben Plesner; Andrzej Jakubowiak
errShare
errSave
FDG-PET Medullary Total Tumor Volume Highlights High-Risk Newly Diagnosed Multiple Myeloma Patients in CASSIOPEIA Trial
err2026-03-31
err0
errOAAI
errBastien Jamet; Shamimeh Ahrari; Sonja Zweegman; Aurore Perrot; Cyrille Hulin; Denis Caillot; Thierry Facon; Xavier Leleu; Karim Belhadj; Emmanuel Itti; Lionel Karlin; Clément Bailly; Mark-David Levin; Monique C. Minnema; Caroline Bodet-Milin; Bart de Keizer; Jill Corre; Pieter Sonneveld; Diana Mateus; Philippe Moreau
errShare
errSave
Isatuximab, bortezomib, lenalidomide, dexamethasone for multiple myeloma: Dynamics of MRD-negativity in the IMROZ study
errBlood
IF23.1
err2026-03-03
err0
errOAAI
errRobert Z. Orlowski; Meletios A. Dimopoulos; Xavier Leleu; Thierry Facon; Tadao Ishida; Roman Hájek; Ivan Špička; Joanna Romejko-Jarosinska; Vladimir Vorobyev; Britta Besemer; Sevgi Kalayoglu Besisik; Pawel Robak; Tomas Jelinek; Hartmut Goldschmidt; Thomas Martin; Mohamad Mohty; Sandrine Macé; Ercem Kodas; Christina Tekle; Andrea T. Shafer
errShare
errSave
Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial
err2026-01-07
err0
errOAAI
errHermann Einsele; Jesús San-Miguel; Binod Dhakal; Cyrille Touzeau; Xavier Leleu; Niels WCJ van de Donk; Surbhi Sidana; Albert Oriol; Yael C Cohen; Simon J Harrison; María-Victoria Mateos; Joaquín Martínez-López; Paolo Corradini; Lionel Karlin; Diana Chen; Quanlin Li; Tzu-min Yeh; Katherine Li; Vicki Plaks; Ana Slaughter
errShare
errSave
35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience
err2025-10-24
err0
errOAAI
errPhilippe Moreau; Cyrille Hulin; Alexis Talbot; Hélène Demarquette; Léo Caillot; Thomas Chalopin; Arthur Bobin; Salomon Manier; Xavier Leleu; Lionel Karlin; Denis Caillot; Cécile Sonntag; Pierre Feugier; Murielle Roussel; Romain Gounot; Margaret Macro; Mohamad Mohty; Laurent Garderet; Mourab Tiab; Frédérique Orsini-Piocelle; Laure Vincent; Nathalie Meuleman; Jean Fontan; Lidia Montes; Marie-Christiane Vekemans; Martine Escoffre-Barbe; Jean-Richard Eveillard; Jean-Marc Schiano de Colella; Jérôme Lambert; Jean-Yves Mary; Jean-Paul Fermand; Bertrand Arnulf; Jill Corre; Hervé Avet-Loiseau; Thierry Facon; Jean-Luc Harousseau; Cyrille Touzeau; Aurore Perrot
errShare
errSave
Debulking strategy prior to anti-BCMA/CD3 bispecific antibodies in extramedullary and/or high tumor burden RRMM: a retrospective cohort study
err2025-10-21
err0
errOAAI
errThomas Chalopin; Elise Cellerin; Hélène Demarquette; Andréa Pieragostini; Cécile Sonntag; Caroline Jaquet; Zoé De Wyngaert; Anne Rumpler; Murielle Roussel; Gaelle Labouré; Véronique Morel; Laure Vincent; Valéry Salle; Titouan Cazaubiel; Arthur Bobin; Anaïs Schavgoulidze; Jill Corre; Xavier Leleu; Salomon Manier
errShare
errSave
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial
err2025-09-29
err0
errOAAI
errSalomon Manier; Jérôme Lambert; Cyrille Hulin; Margaret Macro; Kamel Laribi; Carla Araujo; Gian Matteo Pica; Cyrille Touzeau; Pascal Godmer; Borhane Slama; Lionel Karlin; Frédéric Orsini Piocelle; Mamoun Dib; Laurence Sanhes; Pierre Morel; Abderazzak El Yamani; Mourad Tiab; Reza Tabrizi; Valentine Richez; Laurent Garderet; Bruno Royer; Benoit Bareau; Clara Mariette; Emmanuel Fleck; Daniela Robu; Claire Calmettes; Sophie Rigaudeau; Hélène Demarquette; Laurent Frenzel; Olivier Decaux; Mohamad Mohty; Bertrand Arnulf; Noémie Bigot; Aurore Perrot; Jill Corre; Jean-Yves Mary; Hervé Avet-Loiseau; Philippe Moreau; Xavier Leleu; Thierry Facon
errShare
errSave
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial
errBlood
IF23.1
err2025-09-26
err0
PREAI
errFrançoise Kraeber-Bodéré; Bastien Jamet; Sonja Zweegman; Aurore Perrot; Cyrille Hulin; Denis Caillot; Thierry Facon; Xavier Leleu; Karim Belhadj; Emmanuel Itti; Lionel Karlin; Clément Bailly; Mark-David Levin; Monique C. Minnema; Caroline Bodet-Milin; Bart de Keizer; Jill Corre; Pieter Sonneveld; Philippe Moreau; Thomas Carlier; Cyrille Touzeau
errShare
errSave
High-risk genomic consensus validation in newly diagnosed multiple myeloma patients using next-generation sequencing
errBlood
IF23.1
err2025-09-26
err0
PREAI
errAnaïs Schavgoulidze; Aurore Perrot; Xavier Leleu; Titouan Cazaubiel; Marie-Lorraine Chretien; Pierre Feugier; Karim Belhadj; Salomon Manier; Murielle Roussel; Sabine Brechignac; Frédérique Orsini-Piocelle; Mohamad Mohty; Jean-Marc Schiano de Collela; Margaret Macro; Didier Adiko; Mamoun Dib; Jean Fontan; Carine Luttiau-Motard; Didier Bouscary; Laurent Pascal; Virginie Roland; François Lifermann; Jana Bakala; Lydia Montes; Céline Kennel; Philippe Rey; Valentine Richez; Faiza Keddar; Laurent Frenzel; Claire Calmettes; Carine Chaleteix; Isabelle Plantier; Emilie Chalayer; Anna Schmitt; Christophe Roul; Hélène Demarquette; Chloe Cerutti; Luka Pavageau; Laure Derrier; Hervé Avet-Loiseau; Jill Corre
errShare
errSave
Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study
err2025-09-20
err0
errOAAI
errSarah Cayla; Lionel Karlin; Jérôme Lambert; Anne Lazareth; Alexis Talbot; Mohamad Mohty; Florent Malard; Marie-Odile Petillon; Salomon Manier; Ibrahim Yakoub-Agha; Denis Caillot; Ingrid Lafon; Xavier Leleu; Niels Moya; Bruno Royer; Jean-Marc Schiano De Colella; Gabriel Brisou; Cyrille Touzeau; Aurore Perrot; Pierre Bories; Laure Vincent; Hanane Guedon; Olivier Decaux; Benoît Ferment; Roch Houot; Steven Le Gouill; Noémie Bigot; Thierry Facon; Jill Corre; Hervé Avet-Loiseau; Philippe Moreau; Bertrand Arnulf
errShare
errSave
Risk of synchronous and second primary malignancies in multiple myeloma transplant-ineligible treated with lenalidomide
err2025-08-28
err0
errOAAI
errThomas SYSTCHENKO; Laly NSIALA; Arthur BOBIN; Hélène GARDENEY; Carine MOTARD; Gaelle OLIVIER; Florence BORDE; Anne CORBY; Christophe ROUL; Emmanuel FLECK; Guillaume DENIS; Céline DIEVAL; Philippe MOTTAZ; Annick BOSCAGLI; Gautier DEFOSSEZ; Xavier LELEU
errShare
errSave
Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician’s Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma
err2025-08-06
err0
errOAAI
errCyrille Touzeau; Brea Lipe; Abdullah M. Khan; Binod Dhakal; Sandhya Nair; Jianming He; João Mendes; Seina Lee; Carolina Lonardi; Ana Slaughter; Nikoletta Lendvai; Jordan M. Schecter; Diana Chen; Man Zhao; Tzu-min Yeh; Xavier Leleu; Noemí Puig; Dominik Dytfeld; Elena Zamagni; Katja Weisel; Lionel Karlin; Michel Delforge; Paolo Corradini; Roberto Mina; Wilfried Roeloffzen; Surbhi Sidana
errShare
errSave
Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events
err2025-07-28
err0
errOAAI
errEvangelos Terpos; Suzanne Trudel; María-Victoria Mateos; Nicolás Alejandre; Kathryn Colby; Meletios A. Dimopoulos; Simona Degli Esposti; Asim V. Farooq; Maria Gavriatopoulou; Francesca Gay; Vania Hungria; K. Martin Kortüm; Xavier Leleu; Sagar Lonial; Hang Quach; Lugui Qiu; Karthik Ramasamy; Kazuhito Suzuki; Katja C. Weisel; Paul Richardson
errShare
errSave
Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions
err2025-07-23
err0
errOAAI
errPaul G. Richardson; Elisabeth K. O’Donnell; Peter O’Gorman; Lisa B. Leypoldt; Jacob Laubach; Francesca Gay; Xavier Leleu; Thierry Facon; Philippe Moreau; Meletios A. Dimopoulos; Hartmut Goldschmidt; Elias K. Mai; Michele Cavo; Katja C. Weisel; Jesus G. Berdeja; Robert Z. Orlowski; Meral Beksaç; Aurore Perrot; Joseph Mikhael; Thomas Martin
errShare
errSave
Thromboembolism in transplant-ineligible multiple myeloma patients on triplet/quadruplet therapy: a post-hoc analysis of BENEFIT
err2025-06-14
err0
PREAI
errEmilie Chalayer; Corinne Frere; Elisabeth Daguenet; Thomas Lecompte; Bernard Tardy; Ilhame Bounouara; Manon Sapet; Arthur Bobin; Stephanie Harel; Olivier Decaux; Karim Belhadj; Cyrille Touzeau; Margaret Macro; Mohamad Mohty; Philippe Moreau; Jill Corre; Hervé Avet–Loiseau; Lionel Karlin; Thierry Facon; Aurore Perrot; Cyrille Hulin; Salomon Manier; Laurent Frenzel; Xavier Leleu
errShare
errSave
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison
err2025-05-12
err0
errOAAI
errPuig, N; Diels, J; van Sanden, S; Mendes, J; Burnett, H; Cichewicz, A; Lee, S; Hernando, T; Schecter, JM; Lendvai, N; Patel, N; Sanchez-Pina, JM; Rocchi, S; Mina, R; Corradini, P; Cavo, M; Miguel, JS; Shune, L; Khan, AM; Sidana, S; Leleu, X; Manier, S; Lipe, B; Weisel, K; Martinez-Lopez, J
errShare
errSave
Time for a paradigm shift in immunotherapy-based BCMA/CD3 bispecific drug development in multiple myeloma
errLEUKEMIA
IF13.4
err2025-04-24
err0
PREAI
errLeleu, Xavier; Bobin, Arthur; Herbelin, Andre; Gombert, Jean-Marc; Rajkumar, S. Vincent
errShare
errSave